Cargando…
Bortezomib-based therapy in non-transplant multiple myeloma patients: a retrospective cohort study from the FABIO project
INTRODUCTION: Randomized clinical trials showed that bortezomib, in addition to conventional chemotherapy, improves survival and disease progression in multiple myeloma (MM) patients not eligible for stem cell transplantation. The aim of this retrospective population-based cohort study is the evalua...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905486/ https://www.ncbi.nlm.nih.gov/pubmed/33747423 http://dx.doi.org/10.1177/2040620721996488 |